Results 101 to 110 of about 24,231 (256)

Evaluation of QT prolongation and arrhythmias in drug-resistant tuberculosis patients receiving bedaquiline-containing regimen: a prospective observational study in Eastern India

The Journal of Association of Chest Physicians
Background: Preliminary studies on bedaquiline (BDQ) for drug-resistant tuberculosis (DR-TB) treatment have shown variable incidences of QT interval changes.
S. Raghul Raj, Rupam Kumar Ta, Sandip Mukhopadhyay   +2 more
doaj   +1 more source

A qualitative assessment of quantitative easing sentiment

Economic Inquiry, EarlyView.
Abstract This mixed‐method study undertakes a comprehensive inquiry of the public discourse on social media surrounding quantitative easing (QE) across the US, the UK, and the European Union. Utilizing a unique tweet dataset, we reveal the sentiment polarity toward QE policy to be strongly negative, at 71.27%, with positive sentiment a mere 4.25 ...
Niamh Wylie, Martha O’Hagan‐Luff
wiley   +1 more source

Multifactorial QT interval prolongation.

Cardiology journal, 2010
Acquired long QT interval has been widely reported to be a consequence of drug therapy and electrolyte disturbances. We describe two cases of multifactorial acquired QT interval prolongation and torsades de pointes. In the first case, the drugs venlafaxine, amiodarone and domperidone may have contributed to QT interval prolongation in a patient with ...
Geneviève, Digby, Jimmy, Machaalany, Paul, Malik, Michelle, Methot, Christopher S, Simpson, Damian, Redfearn, Adrian, Baranchuk   +6 more
openaire   +1 more source

Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

European Journal of Haematology, EarlyView.
ABSTRACT Objective This study aimed to evaluate the feasibility and safety of venetoclax as a cytoreductive strategy during induction therapy in newly diagnosed acute promyelocytic leukemia (APL), and to provide an exploratory description of its early efficacy.
Yu Wang, Rong Xiao, Xiaobing Huang, Yi Xiao   +3 more
wiley   +1 more source

Response to equine cardiac adverse events during sports

Equine Veterinary Education, EarlyView.
Summary Cardiac adverse events and sudden death are a feared scenario for equine veterinarians, with serious consequences for animal health, riders' safety and the social licence to operate equestrian sports. The response to equine cardiac adverse events (CAEs) during sports is poorly defined.
C. Navas de Solis, J. Keen, A. Decloedt, B. Delvescovo, K. Hopster, K. Mitchell, J. Slack, G. van Loon, G. Van Steenkiste, L. Nath   +9 more
wiley   +1 more source

Retracted: Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib-Induced QT Interval Prolongation. [PDF]

Oxid Med Cell Longev, 2023
Longevity OMAC.
europepmc   +1 more source

Safety and Utility of Smartphone‐Based Heart Monitors in Pediatric Patients With Cardiovascular Implantable Electronic Devices

Journal of Cardiovascular Electrophysiology, EarlyView.
Smartphone heart monitors in pediatric CIEDs: A pilot study. Smartphone heart monitors did not induce EMI in children with CIEDs, enabling reliable heart rate measurement and accurate identification of ventricular non‐captures. ABSTRACT Background Portable heart monitors enable on‐demand electrocardiogram (ECG) recordings and enhance symptom‐rhythm ...
Chun‐Lok Ho, Sit‐Yee Kwok, Sabrina S. L. Tsao, Yiu‐Fai Cheung   +3 more
wiley   +1 more source

Detection of QT interval prolongation using Apple Watch electrocardiogram in children and adolescents with congenital long QT syndrome. [PDF]

Int J Cardiol Heart Vasc, 2023
Yee-Ming Li J, Kwok SY, Tsao S, Hoi-Yan Chung C, Hing-Sang Wong W, Cheung YF.   +5 more
europepmc   +1 more source

Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction To demonstrate noninferiority of continued sodium zirconium cyclosilicate therapy versus a potassium‐restricted diet in achieving normokalemia at Visit 7 (Days 28–42) in individuals with type 2 diabetes and hyperkalemia, using a noninferiority margin of −10 percentage points (one‐sided α = 0.025).
Masahide Hamaguchi, Junya Hironaka, Hiroshi Okada, Mari Yoneda, Ayaka Kobayashi, Yoshitaka Hashimoto, Aya Kitae, Noriyuki Kitagawa, Akio Kishi, Michiyo Ishii, Mai Asano, Masahiro Yamazaki, Toru Tanaka, Hanako Nakajima, Eiko Sato, Michiaki Fukui   +15 more
wiley   +1 more source

High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study. [PDF]

JMIR Cardio, 2023
Yuan N, Oesterle A, Botting P, Chugh S, Albert C, Ebinger J, Ouyang D.   +6 more
europepmc   +1 more source